What are the etiology, epidemiology, clinical presentation, and management of vesicouterine fistula in women of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vesicouterine Fistula: Etiology, Epidemiology, Presentation, and Management

Etiology

Cesarean section is the overwhelming cause of vesicouterine fistula, accounting for 83-93% of all cases. 1, 2 The risk increases dramatically with repeated cesarean deliveries—rising from 41.3 per 10,000 after two cesarean sections to 230 per 10,000 after five or more procedures. 3

Additional etiologic factors include:

  • Uterine rupture during labor (particularly during trial of labor after cesarean section) 4, 5
  • Radiation therapy for gynecological malignancies 4, 2
  • Iatrogenic injury during other pelvic surgical procedures 1

The mechanism involves unrecognized bladder injury during dissection of the lower uterine segment, which subsequently develops into a fistulous tract between the bladder and uterus. 1

Epidemiology

Vesicouterine fistula is a rare condition, though its prevalence is increasing worldwide due to the rising frequency of cesarean sections. 1 The condition predominantly affects women of reproductive age who have undergone cesarean delivery. 1, 6

Important temporal consideration: The fistula may develop immediately after cesarean section, manifest in the late puerperium, or occur years to decades after the initial procedure—with documented cases presenting up to 30 years later. 1, 6

Clinical Presentation

The pathognomonic triad (Youssef's syndrome) consists of:

  • Vaginal urinary leakage (urinary incontinence through the cervix)
  • Cyclic hematuria (menouria—menstrual blood in urine)
  • Amenorrhea (absence of vaginal menstruation) 1

Additional presenting features include:

  • Recurrent urinary tract infections (observed in 53% of cases) 2
  • Infertility and first-trimester abortions 1
  • Chronic pelvic pain syndrome (27% of cases, typically VAS ≤6) 2

Critical diagnostic clue: Suspect vesicouterine fistula in any woman presenting with urinary incontinence following cesarean section, even decades after the procedure. 6

Diagnostic Approach

Initial Testing

Methylene blue dye test: Instill methylene blue into the bladder and observe for drainage of blue-tinged urine through the cervix—this confirms the diagnosis clinically. 6

Imaging Modalities (in order of diagnostic utility)

Contrast-enhanced helical CT after cystography is the most reliable imaging technique, with diagnostic sensitivity of 76.5% for fistula detection and 94.1% for defining etiology. 4 Water-soluble contrast should be placed in the bladder to opacify the fistulous tract. 4

MRI pelvis with IV contrast provides superior soft-tissue contrast resolution for evaluating fistulous tracts and is particularly useful when CT is inconclusive. 3, 6, 4

Unenhanced helical CT after hysterography can demonstrate the fistula when contrast is instilled through the uterus. 4

Cystography alone may be diagnostic but has variable sensitivity. 4

Important caveat: Color Doppler sonography, excretory urography, cystoscopy, vaginoscopy, and hysterography frequently yield negative or undefined results and should not be relied upon as primary diagnostic tools. 4 The diagnosis is often delayed 3-7 years due to these false-negative studies. 4

Intraoperative detection: Transvaginal or transrectal ultrasound during cesarean section when bladder injury is suspected can allow immediate diagnosis and repair, preventing the need for subsequent surgery and avoiding prolonged morbidity. 1

Management

Conservative Management

Bladder catheterization for 4-8 weeks is indicated when the fistula is discovered immediately after delivery, as spontaneous closure occurs in approximately 5% of cases. 1, 5 One documented case achieved successful closure with 21 days of transurethral Foley catheter drainage. 5

Hormonal management should be attempted in women presenting with Youssef's syndrome (the classic triad). 1

Prerequisites for conservative approach:

  • Early recognition (immediately postpartum)
  • Small fistula size
  • Absence of infection (pretreat any urinary tract infections before attempting repair) 1

Surgical Management

Surgery is the definitive treatment for vesicouterine fistula after failed conservative management or delayed presentation. 1, 2

Surgical Approaches (in order of preference based on outcomes)

Transperitoneal approach is considered most effective with the lowest relapse rate. 1

Minimally invasive techniques (robot-assisted or laparoscopic) achieve equivalent outcomes to open surgery when performed by experienced surgical teams:

  • Robot-assisted approach: Mean operative time 118 minutes (80-140), mean blood loss 82 ml, mean hospital stay 5.2 days 2
  • Laparoscopic approach: Mean operative time 125.5 minutes (90-160), mean blood loss 97 ml, mean hospital stay 6.7 days 2
  • No significant difference in outcomes between robotic and laparoscopic approaches (p>0.05) 2
  • Zero recurrence rate during follow-up from 4 weeks to 10 years 2

Alternative approaches:

  • Transvesical-retroperitoneal access 1
  • Vaginal approach 1
  • Endoscopic treatment (effective only for small fistulas) 1

Surgical Technique Essentials

Standard repair involves:

  • Excision of the fistulous tract
  • Two-layer bladder closure with 2/0 polyglycolic suture 6
  • Consideration of hysterectomy with bilateral oophorectomy in postmenopausal women or those with completed childbearing 6
  • Uterine preservation is possible in 87% of cases (13 of 15 patients in one series) 2

Critical technical points:

  • Ensure complete bladder drainage preoperatively
  • Carefully dissect the lower uterine segment
  • Verify ureteral orifice integrity
  • Interpose omentum or peritoneum between bladder and uterine repairs when possible 1, 5

Fertility Outcomes

Pregnancy rate after repair is 31.25%, with term delivery rate of 25%. 1

Mandatory obstetric management: After vesicouterine fistula repair, all subsequent deliveries should be performed by repeat cesarean section due to high risk of fistula recurrence with vaginal delivery. 1

Prevention Strategies

Intraoperative measures to prevent vesicouterine fistula:

  • Empty the bladder completely before cesarean section 1
  • Carefully dissect the lower uterine segment with clear visualization 1
  • Perform intraoperative transvaginal or transrectal ultrasound when bladder injury is suspected (allows immediate repair and prevents delayed fistula formation) 1
  • Consider filling the bladder with methylene blue during difficult dissections to immediately identify bladder entry 1

Common pitfall: At least 95% of vesicouterine fistulas are diagnosed postoperatively rather than intraoperatively, necessitating a second operation and prolonged patient morbidity. 1 Heightened intraoperative vigilance is essential.

References

3
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

4
Research

Vesicouterine fistulas: imaging findings in three cases.

AJR. American journal of roentgenology, 2005

5
Research

Conservative management of vesicouterine fistula after uterine rupture.

International urogynecology journal and pelvic floor dysfunction, 2004

6
Research

Vesicouterine fistula presenting with urinary incontinence 30 years after primary Cesarean: Case report and review of the literature.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2014

Related Questions

What is the management plan for a post-cesarean section (CS) patient presenting with abdominal pain, tenderness, distension, and a diagnosed small bowel fistula?
What is the best course of action for a woman who develops a small bowel fistula after a cesarean section (CS), presenting with abdominal pain, tenderness, and distension?
Can a vesicouterine fistula occur as a complication of surgeries such as laparotomy, colostomy, or appendectomy in a female patient of reproductive age?
How does a vesicouterine fistula occur in a female of reproductive age with a history of complicated deliveries or uterine surgeries, such as a cesarean section (C-section)?
What is the management approach for a female of reproductive age with a history of complicated deliveries or uterine surgeries presenting with a vesicouterine fistula?
For colorectal carcinoma in situ (Tis) or T1 cancer, when should I choose endoscopic mucosal resection (EMR) versus surgical resection (segmental colectomy with lymphadenectomy)?
How should a confirmed positive Ureaplasma infection be treated, particularly in pregnant or lactating patients?
Is the recommended sequence to extend the pre‑septal (supraperiosteal) dissection to the pre‑maxillary space, then perform a full‑length periosteal release of the arcus marginalis along the inferior orbital rim, and finally open the orbital septum to expose the orbital fat?
In lower‑lid blepharoplasty for typical adult cosmetic patients without significant ocular disease, lid laxity, or wound‑healing comorbidities, is it safe to perform only fat transposition and reserve fat excision only for cases with truly bulky or protruding orbital fat?
What dose of sodium phosphate should be given to an adult with a serum phosphate of 0.39 mmol/L?
In an otherwise healthy adult male with a metal‑induced scrape/laceration under the toe, should the wound be closed with sutures or tissue adhesive, and what prophylactic antibiotics are appropriate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question